Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesOrganized Radiology IssuesLes patients d’abord! Patients first at this year’s JFR meetingJFR president Prof. Isabelle Thomassin-Naggara discusses the importance of the human radiologist for patients, a key theme at this year’s congress.Nuclear MedicineIAEA Scientific Forum: Can automated planning shorten radiotherapy waits?Nuclear MedicineRadiation medicine aims to tackle cancer care inequalities in low-income countriesNuclear MedicineIAEA Scientific Forum: Where you live should not determine access to cancer careInterventionalCIRSE: Studies link ablation margins to liver tumor control